Cancer Gala Board
EIN: 872357986 · Rolla, MO · NTEE: G30
Is Cancer Gala Board Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Cancer Gala Board
Cancer Gala Board (EIN: 872357986) is a nonprofit organization based in Rolla, MO, classified under NTEE code G30. The organization reported total revenue of $281K and total assets of $132K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Cancer Gala Board's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
AI Analysis Pending
AI enrichment for Cancer Gala Board has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Cancer Gala Board with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Frequently Asked Questions about Cancer Gala Board
Is Cancer Gala Board a legitimate charity?
Based on AI analysis of IRS 990 filings, Cancer Gala Board (EIN: 872357986) insufficient data. 0 red flags identified, 0 strengths noted.
How does Cancer Gala Board spend its money?
Detailed spending breakdown data is not yet available for Cancer Gala Board. Check back for updated IRS 990 analysis.
Are donations to Cancer Gala Board tax-deductible?
Cancer Gala Board is registered as a tax-exempt nonprofit (EIN: 872357986). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Filing History
IRS 990 filing history for Cancer Gala Board showing financial trends over 3 years of public records:
Over 3 years of IRS 990 filings (2021–2023), Cancer Gala Board's revenue has grown by 90.4%, moving from $112K to $213K. Total assets increased by 65.6% over the same period, from $108K to $179K. Total functional expenses rose by 6784.8%, from $3K to $233K. In its most recent filing year (2023), Cancer Gala Board reported a deficit of $20K, with expenses exceeding revenue.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. | |
|---|---|---|---|---|---|---|
| 2023 | $213K | $233K | $179K | $0 | — | — |
| 2022 | $147K | $56K | $199K | $0 | — | — |
| 2021 | $112K | $3K | $108K | $0 | — | — |
Year-by-Year Financial Summary
- 2023: Revenue of $213K, expenses of $233K, and assets of $179K (revenue +44.3% year-over-year).
- 2022: Revenue of $147K, expenses of $56K, and assets of $199K (revenue +31.9% year-over-year).
- 2021: Revenue of $112K, expenses of $3K, and assets of $108K.
Data Sources and Methodology
This transparency report for Cancer Gala Board is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.